Roles of serotonergic and adrenergic receptors in the antinociception of selective cyclooxygenase-2 inhibitor in the rat spinal cord

Korean Journal of Pain

Volumn 24, Issue 4, 2011, Pages 179-184

  Jeong, Hye Jin ^a   Lee, Seong Heon ^a   Cho, Soo Young ^a   Lee, Cha Sup ^a   Jeong, Cheol Won ^a   Yoon, Myung Ha ^a   Kim, Woong Mo ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Analgesia; COX 2 inhibitor; Inflammatory pain; Mechanism; Spinal cord

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; DIHYDROERGOCRISTINE; FORMALDEHYDE; NORADRENALIN; PRAZOSIN; SEROTONIN; SEROTONIN RECEPTOR; YOHIMBINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; INFLAMMATORY PAIN; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PROTEIN FUNCTION; RAT; SEROTONINERGIC SYSTEM; SPINAL CORD; WITHDRAWAL REFLEX;

EID: 84861004859     PISSN: 20059159     EISSN: 20930569     Source Type: Journal    
DOI: 10.3344/kjp.2011.24.4.179     Document Type: Article

References (27)

1. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996; 390: 165-9.
2. Choi CH, Kim WM, Lee HG, Jeong CW, Kim CM, Lee SH, et al. Roles of opioid receptor subtype in the spinal antinociception of selective cyclooxygenase 2 inhibitor. Korean J Pain 2010; 23: 236-41.
3. Hamza M, Dionne RA. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol 2009; 2: 1-14.
4. Marlier L, Teilhac JR, Cerruti C, Privat A. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord. Brain Res 1991; 550: 15-23.
5. Hösli E, Hösli L. Evidence for the existence of alpha- and beta-adrenoceptors on neurones and glial cells of cultured rat central nervous system--an autoradiographic study. Neuroscience 1982; 7: 2873-81.
6. Fürst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999; 48: 129-41.
7. Sandrini M, Vitale G, Pini LA. Effect of rofecoxib on nociceptio nand the serotonin system in the rat brain. Inflamm Res 2002; 51: 154-9.
8. Taiwo YO, Levine JD. Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J Neurosci 1988; 8: 1346-9.
9. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6.
10. Choi JI, Yoo KY, Yoon MH. Effect of serotonergic receptors on the antinociception of intrathecal gabapentin in the formalin test of rats. J Korean Pain Soc 2002; 15: 19-25.
11. Coppi G. Dihydroergocristine. A review of pharmacology and toxicology. Arzneimittelforschung 1992; 42: 1381-90.
12. Grognet JM, Rivière R, Istin M, Zanotti A, Coppi G. The pharmacokinetics of dihydroergocristine after intravenous and oral administration in rats. Arzneimittelforschung 1992; 42: 1394-6.
13. Doxey JC, Roach AG, Smith CF. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol 1983; 78: 489-505.
14. Hamilton CA, Reid JL, Vincent J. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit. Br J Pharmacol 1985; 86: 79-87.
15. Hubbard JW, Pfister SL, Biediger AM, Herzig TC, Keeton TK. The pharmacokinetic properties of yohimbine in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol 1988; 337: 583-7.
16. Yoon MH, Choi JI, Jeong SW. Spinal gabapentin and antinociception: mechanisms of action. J Korean Med Sci 2003; 18: 255-61.
17. Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 1996; 64: 345-55.
18. Nishiyama T. Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats. Acta Anaesthesiol Scand 2006; 50: 228-33.
19. Pini LA, Vitale G, Sandrini M. Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid. Pharmacology 1997; 54: 84-91.
20. Vitale G, Pini LA, Ottani A, Sandrini M. Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. Gen Pharmacol 1998; 31: 753-8.
21. Courade JP, Caussade F, Martin K, Besse D, Delchambre C, Hanoun N, et al. Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 534-7.
22. Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiology 2003; 99: 976-81.
23. Fairbanks CA. Spinal delivery of analgesics in experimental models of pain and analgesia. Adv Drug Deliv Rev 2003; 55: 1007-41.
24. Xu JJ, Walla BC, Diaz MF, Fuller GN, Gutstein HB. Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance. Anesth Analg 2006; 103: 714-20.
25. Pinardi G, Sierralta F, Miranda HF. Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems. Inflammation 2001; 25: 233-9.
26. Miranda HF, Sierralta F, Pinardi G. An isobolographic analysis of the adrenergic modulation of diclofenac antinociception. Anesth Analg 2001; 93: 430-5.
27. Miranda HF, Pinardi G. Isobolographic analysis of the antinociceptive interactions of clonidine with nonsteroidal anti-inflammatory drugs. Pharmacol Res 2004; 50: 273-8.